Quick Answer
REGENEREX PHARMA, INC. reported Net Income of -$2.53 million for fiscal year 2025.
REGENEREX PHARMA, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$2.53M | +28.7% |
| 2024 | -$3.54M | -2480.5% |
| 2023 | -$137.3K | +29.8% |
| 2022 | -$195.6K | +44.7% |
| 2021 | -$353.8K | -417.0% |
| 2020 | $111.6K | +219.2% |
| 2019 | -$93.6K | -88.4% |
| 2018 | -$49.7K | -1830.5% |
| 2017 | -$2.6K | -100.3% |
| 2014 | $859.8K | +186.4% |
| 2013 | -$995.5K | -50.9% |
| 2012 | -$659.7K | -211.0% |
| 2011 | -$212.1K | -674.5% |
| 2010 | -$27.4K | -328.7% |
| 2009 | -$6.4K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$814.0K | -53.7% | -22.7% |
| June 30, 2025 | -$663.6K | -143.5% | -111.0% |
| December 31, 2024 | -$314.5K | -19.1% | +40.6% |
| September 30, 2024 | -$529.6K | +81.1% | -94.3% |
| June 30, 2024 | -$272.6K | -46.9% | -3.3% |
| December 31, 2023 | -$264.0K | -434.4% | +90.6% |
| September 30, 2023 | -$2.80M | -15095.5% | -1409.6% |
| June 30, 2023 | -$185.6K | -699.8% | -275.7% |
- REGENEREX PHARMA, INC. showed an increase of +28.7% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, REGENEREX PHARMA, INC.’s net income has declined by 39453.0% (from -$6.4 thousand to -$2.53 million).
- The most recent figure is from REGENEREX PHARMA, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: